These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11343214

  • 1. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP, Carvalho FA, Tavares CA, Santiago HC, Castro GA, Tafuri WL, Ferreira LA, Gazzinelli RT.
    J Infect Dis; 2001 Jun 01; 183(11):1646-52. PubMed ID: 11343214
    [Abstract] [Full Text] [Related]

  • 2. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 01; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 3. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr 01; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 4. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD, Huang X, McClellan SA, Barrett RP.
    Eye (Lond); 2003 Nov 01; 17(8):863-71. PubMed ID: 14631390
    [Abstract] [Full Text] [Related]

  • 5. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Rafati S.
    Appl Microbiol Biotechnol; 2016 Aug 01; 100(16):7051-60. PubMed ID: 26960322
    [Abstract] [Full Text] [Related]

  • 6. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica.
    Kumar R, Bumb RA, Salotra P.
    FEMS Immunol Med Microbiol; 2009 Dec 01; 57(3):239-46. PubMed ID: 19799628
    [Abstract] [Full Text] [Related]

  • 7. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Dec 01; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 8. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA, Marco JD, Calvopina M, Kato H, Korenaga M, Hashiguchi Y.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1123-9. PubMed ID: 17439977
    [Abstract] [Full Text] [Related]

  • 9. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM, Bonafonte MT, Campbell LD, Mead JR.
    Exp Parasitol; 2001 Jul 01; 98(3):123-33. PubMed ID: 11527435
    [Abstract] [Full Text] [Related]

  • 10. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 12. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
    Chen L, Zhang ZH, Watanabe T, Yamashita T, Kobayakawa T, Kaneko A, Fujiwara H, Sendo F.
    Parasitol Int; 2005 Jun 28; 54(2):109-18. PubMed ID: 15866472
    [Abstract] [Full Text] [Related]

  • 13. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG, Pereira AM, Fernandes AP, Ferreira LA.
    Antimicrob Agents Chemother; 2010 Nov 28; 54(11):4699-704. PubMed ID: 20713665
    [Abstract] [Full Text] [Related]

  • 14. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y, Ishii K, Hisaeda H, Hamano S, Zhang M, Nakanishi K, Yoshimoto T, Hemmi H, Takeda K, Akira S, Iwakura Y, Himeno K.
    Gene Ther; 2004 Jun 28; 11(11):941-8. PubMed ID: 14985787
    [Abstract] [Full Text] [Related]

  • 15. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar 28; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 16. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Badirzadeh A, Rafati S.
    Parasite Immunol; 2016 Oct 28; 38(10):599-608. PubMed ID: 27213964
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.
    Behforouz NC, Wenger CD, Mathison BA.
    J Immunol; 1986 Apr 15; 136(8):3067-75. PubMed ID: 3958489
    [Abstract] [Full Text] [Related]

  • 18. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.
    J Dermatol Sci; 2018 Oct 15; 92(1):78-88. PubMed ID: 30037731
    [Abstract] [Full Text] [Related]

  • 19. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J, Sneier R, Elias E.
    Isr J Med Sci; 1992 Dec 15; 28(12):847-51. PubMed ID: 1286954
    [Abstract] [Full Text] [Related]

  • 20. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A, de Cássia Bittar R, Dos Santos Nogueira R, Amato VS, da Silva Mattos M, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM.
    Clin Exp Immunol; 2007 Sep 15; 149(3):440-4. PubMed ID: 17614975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.